Amanote Research
Register
Sign In
The Antifibrotic Agents Treatment in the Idiopathic Pulmonary Fibrosis Patients of Taiwan‐ the Real‐world Experience From Cheng‐hsin General Hospital
Respirology
- United Kingdom
doi 10.1111/resp.13700_490
Full Text
Open PDF
Abstract
Available in
full text
Categories
Pulmonary
Respiratory Medicine
Date
November 1, 2019
Authors
Unknown
Publisher
Wiley
Related search
FRI0461 Efficacy and Safety of Antifibrotic Agents in Idiopathic Pulmonary Fibrosis
Idiopathic Pulmonary Fibrosis (IPF) ― Common Practice in Poland Before the “Antifibrotic Drugs Era”
Advances in Respiratory Medicine
Pulmonary
Respiratory Medicine
Pharmacological Treatment of Idiopathic Pulmonary Fibrosis: From the Past to the Future
European Respiratory Review
Pulmonary
Respiratory Medicine
Comparison of the Antifibrotic Effects of the Pan-Histone Deacetylase-Inhibitor Panobinostat Versus the IPF-drug Pirfenidone in Fibroblasts From Patients With Idiopathic Pulmonary Fibrosis
PLoS ONE
Multidisciplinary
Idiopathic Pulmonary Fibrosis: What Is the Best Treatment?
Barcelona Respiratory Network
Prs58 - Patients With Idiopathic Pulmonary Fibrosis (Ipf): What Happens Before the Diagnosis? A Real-World, Retrospective, Primary Care Database Analysis
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
The Pathogenesis of Idiopathic Pulmonary Fibrosis
Therapeutic Advances in Respiratory Disease
Pulmonary
Respiratory Medicine
Pharmacology
Philosophy (I-Li) Versus Philology (K'Ao-Cheng): The Jen-Hsin Tao-Hsin Debate
T'oung Pao
Linguistics
Literature
Language
Literary Theory
Cultural Studies
Philosophy of Science
History
Beyond Idiopathic Pulmonary Fibrosis: The World of Progressive-Fibrosing Interstitial Lung Disease
European Respiratory Review
Pulmonary
Respiratory Medicine
